AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
MediWound Ltd.
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG005ZPKSG3
12.00▼ 0.18 (-1.48%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
12.18
Day's Range
11.89 – 12.20
52-Week Range
11.84 – 19.70
Volume
79.3K
Avg Volume
86.7K
Share Statistics
Shares Outstanding
Employees
121
Exchange
XNAS
Listed
2014-03-20
Share count as of December 31, 2025

MediWound Ltd. (MDWD) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about MediWound Ltd. (MDWD)
What is MediWound Ltd.'s Market Cap?
MediWound Ltd.'s Market Cap is $154.0M, based on as-reported figures from SEC (XBRL) filings.
What is MediWound Ltd.'s Enterprise Value?
MediWound Ltd.'s Enterprise Value is $149.2M, based on as-reported figures from SEC (XBRL) filings.
What is MediWound Ltd.'s Price / Sales?
MediWound Ltd.'s Price / Sales is 9.1×, based on as-reported figures from SEC (XBRL) filings.
What is MediWound Ltd.'s EV / Revenue?
MediWound Ltd.'s EV / Revenue is 8.8×, based on as-reported figures from SEC (XBRL) filings.
What is MediWound Ltd.'s EV / EBITDA?
MediWound Ltd.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is MediWound Ltd.'s Revenue (TTM)?
MediWound Ltd.'s Revenue (TTM) is $17.0M, based on as-reported figures from SEC (XBRL) filings.
What is MediWound Ltd.'s Net Income (TTM)?
MediWound Ltd.'s Net Income (TTM) is -$23.9M, based on as-reported figures from SEC (XBRL) filings.
What is MediWound Ltd.'s EBITDA?
MediWound Ltd.'s EBITDA is -$24.7M, based on as-reported figures from SEC (XBRL) filings.
What is MediWound Ltd.'s Diluted EPS (TTM)?
MediWound Ltd.'s Diluted EPS (TTM) is -1.86, based on as-reported figures from SEC (XBRL) filings.
What is MediWound Ltd.'s EBITDA Margin?
MediWound Ltd.'s EBITDA Margin is -145.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · MDWDAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Profit or loss [abstract]
Revenues from sale of products
Revenues from development services
Revenues from license agreements and royalties
Total revenues
Cost of revenues from sale of products
Cost of revenues from development services
Cost of revenues from license agreements and royalties
Total cost of revenues
Gross profit
Research and development
Operating Income
Selling, General and Administrative Expense
Other (income) expenses
Total operating expenses
Operating loss
Finance income
Finance expense
Financing income (expenses), net
Loss before taxes on income
Taxes on income
Net loss